Macrocytic anemia overview: Difference between revisions
(Created page with "==Overview== '''Macrocytosis''' is the enlargement of red blood cells with near-constant haemoglobin concentration, and is defined by a mean corpuscular volume (MC...") |
|||
Line 1: | Line 1: | ||
{{Macrocytic anemia}} | |||
{{CMG}} | |||
==Overview== | ==Overview== | ||
'''Macrocytosis''' is the enlargement of [[red blood cell]]s with near-constant [[haemoglobin]] concentration, and is defined by a [[mean corpuscular volume]] (MCV) of greater than 100 femtolitres (the precise criterion varies between laboratories). '''Megaloblastic anemia''' is an [[anemia]] (of [[macrocytic anaemia|macrocytic]] classification) which results from inhibition of DNA synthesis in red blood cell production. It is often due to deficiency of [[vitamin B12]] and/or [[folic acid]]. It can be the result of a lack of [[intrinsic factor]] (which lack interferes with B12 absorption), causing [[pernicious anemia]], or with other antimetabolites which poison DNA production, such as chemotherapeutic agents. It is characterized by many large immature and dysfunctional red blood cells ([[megaloblasts]]) in the bone marrow, and also by hypersegmented or multisegmented [[neutrophil]]s. <ref>Babior BM, Bunn HF, Megaloblastic Anemias. Harrison’s Principles of Internal Medicine. 13th Ed. 1994: 1726-1732. ISBN 0070323704</ref> <ref>Toh BH, van Driel IR, Gleeson PA. Mechanisms of Disease: Pernicious Anemia. NEJM 1997;337:1441.</ref> | '''Macrocytosis''' is the enlargement of [[red blood cell]]s with near-constant [[haemoglobin]] concentration, and is defined by a [[mean corpuscular volume]] (MCV) of greater than 100 femtolitres (the precise criterion varies between laboratories). '''Megaloblastic anemia''' is an [[anemia]] (of [[macrocytic anaemia|macrocytic]] classification) which results from inhibition of DNA synthesis in red blood cell production. It is often due to deficiency of [[vitamin B12]] and/or [[folic acid]]. It can be the result of a lack of [[intrinsic factor]] (which lack interferes with B12 absorption), causing [[pernicious anemia]], or with other antimetabolites which poison DNA production, such as chemotherapeutic agents. It is characterized by many large immature and dysfunctional red blood cells ([[megaloblasts]]) in the bone marrow, and also by hypersegmented or multisegmented [[neutrophil]]s. <ref>Babior BM, Bunn HF, Megaloblastic Anemias. Harrison’s Principles of Internal Medicine. 13th Ed. 1994: 1726-1732. ISBN 0070323704</ref> <ref>Toh BH, van Driel IR, Gleeson PA. Mechanisms of Disease: Pernicious Anemia. NEJM 1997;337:1441.</ref> | ||
==References== | |||
{{Reflist|2}} | |||
[[es:Anemia megaloblástica]] | |||
[[gl:Anemia megaloblástica]] | |||
[[he:אנמיה מגלובלסטית]] | |||
[[it:Anemia megaloblastica]] | |||
[[pl:Niedokrwistość megaloblastyczna]] | |||
[[pt:Anemia megaloblástica]] | |||
[[ru:Пернициозная анемия]] | |||
[[sl:Megaloblastna anemija]] | |||
[[sr:Мегалобластна анемија]] | |||
[[tr:Megaloblastik anemi]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Disease]] | |||
[[Category:Blood disorders]] | |||
[[Category:Hematology]] |
Revision as of 14:11, 21 September 2012
Macrocytic anemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Macrocytic anemia overview On the Web |
American Roentgen Ray Society Images of Macrocytic anemia overview |
Risk calculators and risk factors for Macrocytic anemia overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Macrocytosis is the enlargement of red blood cells with near-constant haemoglobin concentration, and is defined by a mean corpuscular volume (MCV) of greater than 100 femtolitres (the precise criterion varies between laboratories). Megaloblastic anemia is an anemia (of macrocytic classification) which results from inhibition of DNA synthesis in red blood cell production. It is often due to deficiency of vitamin B12 and/or folic acid. It can be the result of a lack of intrinsic factor (which lack interferes with B12 absorption), causing pernicious anemia, or with other antimetabolites which poison DNA production, such as chemotherapeutic agents. It is characterized by many large immature and dysfunctional red blood cells (megaloblasts) in the bone marrow, and also by hypersegmented or multisegmented neutrophils. [1] [2]
References
gl:Anemia megaloblástica he:אנמיה מגלובלסטית it:Anemia megaloblastica sl:Megaloblastna anemija sr:Мегалобластна анемија